[HTML][HTML] Novel systemic inflammation markers to predict COVID-19 prognosis

A Karimi, P Shobeiri, A Kulasinghe… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic, challenging both
the medical and scientific community for the development of novel vaccines and a greater …

[HTML][HTML] COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review

SA SeyedAlinaghi, A Karimi, A Barzegary… - European Journal of …, 2022 - Springer
Introduction Patients with immunodeficiency are usually more prone to worse outcomes of
infectious diseases. However, there are some disagreements in the context of COVID-19, for …

[HTML][HTML] Increased risk of COVID-19 in patients with diabetes mellitus—Current challenges in pathophysiology, treatment and prevention

T Gęca, K Wojtowicz, P Guzik, T Góra - International journal of …, 2022 - mdpi.com
Coronavirus disease—COVID-19 (coronavirus disease 2019) has become the cause of the
global pandemic in the last three years. Its etiological factor is SARS-CoV-2 (Severe Acute …

[HTML][HTML] Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review

V Viswanathan, A Puvvula, AD Jamthikar… - World journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic where several
comorbidities have been shown to have a significant effect on mortality. Patients with …

Evidence of SARS-CoV-2 infection in cells, tissues, and organs and the risk of transmission through transplantation

A Gaussen, L Hornby, G Rockl, S O'Brien… - …, 2021 - journals.lww.com
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus
responsible for the coronavirus disease 2019 (COVID-19) pandemic has raised concerns for …

[HTML][HTML] Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage

N Kirtipal, S Kumar, SK Dubey, VD Dwivedi… - Infection, Genetics and …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), accountable for causing
the coronavirus diseases 2019 (COVID-19), is already declared as a pandemic disease …

[HTML][HTML] Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea

IS Kang, KA Kong - PloS one, 2021 - journals.plos.org
Objective Obesity has been reported as a risk factor for severe coronavirus disease 2019
(COVID-19) in recent studies. However, the relationship between body mass index (BMI) …

Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19

P Hegyi, Z Szakács, M Sahin-Tóth - Gastroenterology, 2020 - gastrojournal.org
(COVID-19) has become a pandemic affecting> 7 million people worldwide so far. 1 The
relatively high mortality of COVID-19 (around 10% of closed cases) is often linked to …

[HTML][HTML] Marked elevation of lipase in COVID-19 disease: a cohort study

U Barlass, B Wiliams, K Dhana, D Adnan… - Clinical and …, 2020 - journals.lww.com
METHODS: Data about demographics, symptoms, laboratory values, and clinical outcomes
were collected for 1,003 consecutive patients testing positive for COVID-19. Elevated lipase …

[HTML][HTML] Emerging neurological and psychobiological aspects of COVID-19 infection

L Tancheva, MC Petralia, S Miteva, S Dragomanova… - Brain sciences, 2020 - mdpi.com
The SARS-CoV-2 virus, first reported in December 2019 in China, is the causative agent of
the current COVID-19 pandemic that, at the time of writing (1 November 2020) has infected …